Acasti Pharma【ACST】株式ニュース

名称	銘柄コード	市場	種別
Acasti Pharma Inc	ACST	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0285	-0.97%	2.90	08:50:01

始値	安値	高値	終値	前日終値
2.93	2.7701	3.1252	2.90	2.9285

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/2/12	22:00	EDGAR2	Form 8-K - Current report
2024/2/12	21:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/1/08	22:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/1/08	21:30	EDGAR2	Form 8-K - Current report
2023/12/21	06:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	21:30	EDGAR2	Form 8-K - Current report
2023/11/13	21:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24	05:30	EDGAR2	Form 8-K - Current report
2023/10/17	05:31	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/12	05:30	EDGAR2	Form 8-K - Current report
2023/10/07	05:30	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/9/28	08:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/26	21:10	EDGAR2	Form 8-K - Current report
2023/9/06	04:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/26	06:01	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2023/8/26	05:21	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2023/8/26	05:15	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/8/11	20:31	EDGAR2	Form 8-K - Current report
2023/8/11	20:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/25	06:30	EDGAR2	Form 8-K - Current report
2023/7/19	05:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/19	05:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/10	22:00	PRNUS	Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON..
2023/7/07	21:30	EDGAR2	Form 8-K - Current report
2023/7/07	21:00	PRNUS	Acasti Pharma Announces 1-for-6 Reverse Stock Split
2023/7/06	05:00	EDGAR2	Form 8-K - Current report
2023/7/05	22:00	PRNUS	Acasti Announces Alignment with FDA on GTX-104 Pivotal Phase..
2023/6/23	20:00	PRNUS	Acasti Pharma Reports Fiscal Year 2023 Operational Results
2023/6/22	22:00	PRNUS	Acasti Announces Appointment of New Scientific Advisory..
2023/5/17	22:00	PRNUS	Acasti to Participate in the Lytham Partners Spring 2023..
2023/5/08	20:00	PRNUS	Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety..

この銘柄に関するニュースをもっと見る »

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

ACST Acasti Pharma Inc

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Acasti Pharma Inc (ACST) ニュース

ACST Acasti Pharma Inc

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手